Quantum Computing is trading at $6.72, up 8.54%, amid attention to its INmune Bio collaboration. - Announced October 14, the project is described as the company’s first commercial pharmaceutical and biotechnology customer. - It uses the Dirac-3S optimization machine, AI and data analytics to research potential new uses for an investigational Alzheimer’s treatment. - Coverage presents the collaboration as a commercial milestone but does not independently confirm it caused the October 16 gain. Broader market readings are mixed, with no same-direction index move above 0.5%.